After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…
OTTAWA, ON, June 12, 2025 /PRNewswire/ -- Solace, the leader in powering real-time, event-driven integration for the agentic age, announced…
What if your favorite superhero story was already unfolding, in your own life? Stories With Purpose is now available worldwide as…